Home » Newsletters » BioWorld

BioWorld

April 12, 2000

View Archived Issues

Appointments and Advancements

Other News To Note

Xanthon Raises $12M For Launch Of Analysis System

Aphton Starts Phase III Study In Metastatic Prostate Cancer

Phage Display Finds Peptides That Block Clotting Cascade, Point To Thrombosis Therapy

Exelixis Bucks Trend, Raises $118M Through Initial Offering

Advisory Panel Recommends Immunex's Enbrel For Early RA

DiaDexus Placement Draws $102M To Find Biomarkers

ViroPharma's Pleconaril Fails To Meet Endpoints In Phase III Trials